Venture
![LOGO 6-01 LOGO 6-01](https://firstxfounder.com/wp-content/uploads/2018/07/LOGO-6-01-2-1024x1024.png)
Affiliations
Columbia University
Technologies
Therapeutic
Indication
Basic Research
Central Nervous System Disorders
Pain Management
Website
www.kuresinc.comI am developing improved analogs of the known antidepressant, tianeptine, which acts through a novel mechanism of action, as new therapies for treatment-resistant depression.
Kures, Inc. Team: